CHAF1B and hepatocellular carcinoma: Moreover, our preliminary bioinformatic analysis suggested that the expression of CHAF1B is positively correlated with overall survival (OS) in HCC patients treated with sorafenib, indicating that CHAF1B may play a role in sorafenib resistance in HCC.